EuLV™ Lentiviral Vector Stable Producer Cell Line Production System

The EuLV™ system, a stable lentiviral vector production system, employs inducible suspension-based producer cell lines in the high cell-density, serum-free media to produce lentiviral vectors.
The EuLV™ stable system emerges as the ideal option for large-scale LVV manufacturing because of:
• Streamlined vector production: No addition of raw materials such as DNA plasmids and transfection reagents.
• Scalable vector production: the serum-free suspension cell culture process is easier to scale up.
• Higher titer yield and simpler process development.
• Reproducible vector production: To produce safer viral vectors with low batch-to-batch variability.

Advantages
• A 50% Reduction in Production Procedure
• An 80% Reduction in Production Costs
• A 100-Fold Increase in Production Efficiency

The path to reliable and scalable lentiviral vectors production
• High-yield
Generates stable clones with high titers up to 5.4E11 TU/L (10~100 higher than Transient Titer).
• Cost-effective
Eliminates total plasmids manufacturing cost.
• Scalable
Produces large amounts of LVV in the serum-free suspension HEK293T system.
• Reproducible
Eliminates variable transient transfection processes
• Fast
Delivers research cell bank (RCB) in as fast as 5 months
• Plug-and-Go
GMP-compliant stable cell line, free of operation